Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes

BACKGROUND: Multiple phase I-II clinical trials have reported on the efficacy and safety of prostate stereotactic body radiotherapy (SBRT) for the treatment of prostate cancer. However, few have reported outcomes for prostate SBRT using periprostatic hydrogel spacer (SpaceOAR; Augmenix). Herein, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Mark E., Mayeda, Mark, Liz, Maria, Goode-Marshall, Brenda, Gonzalez, Lissette, Elliston, Carl D., Spina, Catherine S., Padilla, Oscar A., Wenske, Sven, Deutsch, Israel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679492/
https://www.ncbi.nlm.nih.gov/pubmed/31375119
http://dx.doi.org/10.1186/s13014-019-1346-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679492/
https://www.ncbi.nlm.nih.gov/pubmed/31375119
http://dx.doi.org/10.1186/s13014-019-1346-5

Ejemplares similares